
Scapa (SCPA) was pushed into a first-half loss by medical technology group ConvaTec’s (CTEC) decision to exit a supply deal early, over which Scapa is pursuing $83m (£64m) in damages.
Scapa (SCPA) was pushed into a first-half loss by medical technology group ConvaTec’s (CTEC) decision to exit a supply deal early, over which Scapa is pursuing $83m (£64m) in damages.
Full access for just £3.37 a week:
• Tips and recommendations - to beat the market
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office